New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 1, 2013
07:05 EDTBCR, BCRC.R. Bard downgraded to Sell from Underperform at CLSA
CLSA downgraded CR Bard based on concerns its risk profile has increased with its new multi-year-plan following disappointing guidance. Price target lowered to $96 from $98.
News For BCR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 20, 2015
06:32 EDTBCRC.R. Bard upgraded to Neutral from Underweight at JPMorgan
JPMorgan upgraded C.R. Bard to Neutral on expectations drug-coated balloons growth in the U.S. is likely to exceed consensus expectations. The firm raised its price target for shares to $178 from $162.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use